update

Latest news articles about update

Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook

BBLG

(NASDAQ:BBLG) BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces that President and Chief Executive Officer Jeffrey Frelick has issued the following letter to stockholders. To My Fellow Stockholders: I am pleased to provide a progress report on Bone Biologics’ development of NB1 and to review our expected milestones for the coming year, including the anticipated com

September 4, 2025Read more →

enCore Energy Corp. Hosts Corporate Update

EU

NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS, Aug. 25, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy CompanyTM, today announced William M. Sheriff, Executive Chairman, and Robert Willette, A/Chief Executive Officer...

August 25, 2025Read more →

Shuttle Pharma Provides Second Quarter 2025 Corporate Update

SHPH

GAITHERSBURG, Md., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today provided a corporate update.

August 14, 2025Read more →

MDWerks Issues Mid-Year Shareholder Update

MDWK

GREEN COVE SPRINGS, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- MDWerks, Inc. (“MDWerks” or the “Company”) (OTCQB: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today issued the following mid-year shareholder update from its Chief Executive Officer, Steven Laker.

August 14, 2025Read more →

SKYX Announces Corporate Update Call Including New Developments

SKYX

SKYX Announces Corporate Update Call Including New Developments

August 7, 2025Read more →

Acadia Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference

ACAD

SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will participate in a fireside chat at Canaccord Genuity 45th Annual Growth Conference on Wednesday, August 13, 2025 at 2:30 p.m. Eastern Time. A live webcast of Acadia’s fireside chat will be accessible on the company’s website, Acadia.com, under the investors section and an archived recording will be available on the website for approximately one month following the presentation. About Acadia Pharma

August 5, 2025Read more →

Faraday Future Founder and Co-CEO, YT Jia, Shares Weekly Investor Update

FFAI

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, today shared a weekly business update from YT Jia, Founder and Co-CEO of FF. It’s time for Issue 007 of the Weekly Investor Update. This week brings several seismic developments we’re excited to share with you. Again, starting with S1 User Ecosystem First, we’ve achieved another breakthr

June 16, 2025Read more →

A-CAP Provides Business Update

NEW YORK--(BUSINESS WIRE)--A-CAP Group (“A-CAP” or “the Company”), a New York-based insurance and financial services company with over $12 billion in assets, shared a business update today, including a financial update as of March 31, 2025, updates to product offerings, as well as several important operational developments. Utah & South Carolina Regulatory Update In May 2025, A-CAP and insurance regulators in Utah agreed to the dismissal of a rehabilitation petition and Judge Amber Mettler

June 13, 2025Read more →

Resilience Provides Customers With Update on CDMO Business Strategy and Manufacturing Footprint

SAN DIEGO & CINCINNATI--(BUSINESS WIRE)--National Resilience (“Resilience”), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today provided an update on its CDMO business strategy and financing in a letter to its customers. The full letter follows: Dear Resilience Customers, Since our founding in 2020, Resilience has focused on improving the pharmaceutical supply chain and providing manufacturers of complex, advanced medicines the ability to pr

June 9, 2025Read more →